Keywords: bpd/inhale, sheffield, work, migraine, drug, bradford, particle
BPD/Inhale and Sheffield to work on migraine drug
Article | 06 May 2002
Bradford Particle Design, a wholly-owned subsidiary of InhaleTherapeutic Systems, has entered into a deal with Sheffield Pharmaceuticals to develop a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
